- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06705205
Short, Animated Storytelling (SAS) for Addiction Stigma Reduction (SAS)
September 1, 2025 updated by: Maya Adam, Stanford University
Short, Animated Storytelling Video to Reduce Addiction Stigma: Protocol for a Multi-country, Online, Randomized, Controlled Trial With 13,500 Participants
Stigma towards people with addiction is a well-documented problem that negatively impacts help-seeking, treatment and recovery.
Social contact with people recovering from addiction can promote empathy and reduce stigma, but social contact is difficult to scale.
Short, animated storytelling (SAS) is a novel health communication approach that scales easily because it can leapfrog barriers associated with language, culture, literacy and education levels.
This study will investigate if a SAS video intervention can be used to reduce stigma, boost optimism and hope, and increasing empathy towards people with addiction.
The study will also explore mechanisms of action of SAS interventions, by measuring the contribution of sound design to the effect of the intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13397
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 95305
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adults with basic English proficiency between the ages of 18-49
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SAS video full intervention group
Participants view the full SAS video intervention with sound on Day 1.
|
The intervention is a short, animated storytelling video, with soundtrack, aimed at reducing addiction stigma.
Other Names:
|
|
Experimental: SAS video partial intervention (without sound)
Participants view the partial SAS video intervention without sound on Day 1.
|
The intervention is a short, animated storytelling video, with soundtrack, aimed at reducing addiction stigma.
Other Names:
|
|
No Intervention: Active Control Group
Participants read written information about addiction prevalence
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Addiction Stigma Scale Score as measured by the Attribution Questionnaire (AQ)
Time Frame: Immediately post-intervention on Day 1 and after two weeks
|
Participants complete an 18-item shortened version of the validated AQ.
The AQ-18 will be scored along a 9-point Likert scale indicating the extent to which participants agree with the item ranging from "not at all" to "very much" with a maximum score of 27 for each 3-item construct.
Higher scores indicate greater stigma.
|
Immediately post-intervention on Day 1 and after two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Optimism Scale Score
Time Frame: Immediately post-intervention on Day 1 and after two weeks
|
Participants complete the Brief García's Interactive Optimism Scale (BIOS-G).
The BIOS-G is an instrument designed to assess an individual's level of general optimism towards their life and other people.
The scale includes 4 statements for which respondents indicate their level of agreement from 1 ("Of course not") to 4 ("Yes, of course").
Higher scores indicate a greater level of optimism.
|
Immediately post-intervention on Day 1 and after two weeks
|
|
Change in Attitude Thermometer Score
Time Frame: Immediately post-intervention on Day 1 and after two weeks
|
Participants will indicate their warmth towards subject using a self-report stigma thermometer.
Using a scale scores from zero to 100, with higher scores indicating more empathy or more favorable attitudes.
|
Immediately post-intervention on Day 1 and after two weeks
|
|
Change in Levels of Hope using a visual analogue scale (VAS)
Time Frame: Immediately post-intervention on Day 1 and after two weeks
|
Participants self-report levels of hope using a VAS, a longstanding, validated tool for assessing related constructs of stress and subjective well-being.
The scale goes from zero to 100 and higher scores indicate higher levels of hope.
|
Immediately post-intervention on Day 1 and after two weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maya Adam, MD, PhD, Stanford University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 3, 2025
Primary Completion (Actual)
August 22, 2025
Study Completion (Actual)
August 22, 2025
Study Registration Dates
First Submitted
November 22, 2024
First Submitted That Met QC Criteria
November 22, 2024
First Posted (Actual)
November 26, 2024
Study Record Updates
Last Update Posted (Estimated)
September 3, 2025
Last Update Submitted That Met QC Criteria
September 1, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 76457
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All data will be made available via the Stanford Medicine Research Repository.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.